Strengthening scientific reporting, data integrity, and laboratory workflows through technology and automation. Drug development is becoming more complex. Bioanalytical laboratories need efficient workflows, reliable data, and clear reporting to support this work. KCAS Bio is investing in technology to strengthen these capabilities. Through a new partnership with…

KCAS Bio has been named the recipient of the 2026 Bioz Rising Star™ Award in the Biomarker Analysis category, recognizing the company’s growing presence and impact in scientific research. The Bioz Stars Awards recognize suppliers whose products and technologies contribute to scientific progress, using publication-based evidence to evaluate…

KCAS Bio scientists contributed to an industry working group publication addressing the development and validation of quantitative PCR (qPCR) and digital PCR (dPCR) assays used in regulated bioanalysis for cell and gene therapies. The publication has been recognized as a 2026 High Impact Article by the AAPS Journal.

KCAS Bio’s Ryan Darling, Associate Director of Mass Spectrometry Bioanalysis, will present at the SCIEX Summit 2026 on Wednesday, October 7, as part of Day 2 of the virtual event. Advancing Ultrasensitive Bioanalysis for Complex Modalities Ryan’s presentation, “Ultrasensitive multiplexed bioanalysis of complex modalities using the SCIEX 7500+…

KCAS Bio’s Rathna Veeramachaneni, PhD, will join the 4th Annual Virtual Phenomenex BioSymposium on September 15, sharing insights into advanced LC–MS/MS approaches for the bioanalysis of complex antibody conjugates. Advancing Bioanalysis for Complex Antibody Conjugates Rathna’s presentation, “Magnetic Bead-Enabled Hybrid and Enhanced Traditional LC–MS/MS Workflows for the Bioanalysis…

KCAS Bio is pleased to announce that Dr Mouhssin Oufir, General Manager of KCAS Bio Lyon, was recently featured on Paroles d’Entreprises, broadcast on BFM Business and hosted by Vincent Touraine. During the interview, he shared insights into how the group KCAS Bio supports pharmaceutical and…

In modern bioanalytical research, data quality remains the defining metric of success. At the same time, study complexity continues to increase. KCAS Bio is advancing its global flow cytometry services with a focused strategy that integrates AI-enabled efficiencies, harmonized workflows, and high-parameter technologies. The goal…

KCAS Bio is proud to announce that its EU site (Lyon, France) has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP), confirming its ability to deliver GLP-grade bioanalytical methods in support of preclinical studies. Our GLP test facility was granted a Level of compliance “A”, reinforcing KCAS Bio’s…

KCAS Bio is now a Certified Service Provider (CSP) for the ArgoTM HT platform, offering NULISATM services using Alamar Biosciences technology. Our team is fully trained on the Argo™ HT platform to deliver high-quality, reliable, and highly sensitive assay results, whether using custom single-plex assays for…

KCAS Bio has officially received the Scientist.com Supplier Recognition Award for outstanding performance in offering drug discovery research services on their R&D sourcing platform for 2025. KCAS Bio’s contibutions were recognized to enhance research efficiency worldwide. This award was evaluated based on responsiveness – the time…

As part of our CSR/ESG initiatives launched in 2024-2025, we are proud to share the results of our first EcoVadis sustainability assessment, received in late October, with scores of 60/100 for our EU site (Lyon, France) and 55 for our US sites (KC and PHL). EcoVadis, the world’s most trusted provider of business sustainability ratings, has given us valuable insights into how we…

OLATHE, Kan.–(BUSINESS WIRE)–KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic…